US Weighs Allowing Most Pharma Licensing Deals With China, Sources Say

3-line summary

• The US is weighing allowing most pharma licensing deals with China, according to an exclusive Reuters report via Investing.com.

This summary is our own processing of the source article; see the source link below for full context.